Abstract:[Objective] Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the third major gene of autosomal dominant hypercholesterolemia (ADH). Gain-of-function mutations of PCSK9 are directly associated with human familial hypercholesterolemia, such as theD374Y mutant. In vitro detection experimental results on the degradation of LDLR by the PCSK9 D374Y mutant showed that its LDLR degradation ability is ten times stronger than that of the wild-type protein. This ability increases the risk of hypercholesterolemia, and promotes atherosclerotic lesions. The miniature pig is a useful animal model for biomedical research. However the utility of pigs for diseases model preparation is relatively infrequent because of their individual differences. Inbred lines increased the consistency of the genetic background of the experimental animals, thus consequently, would simplify disease progression of the animal model. This study used Wuzhishan minipig intending to make a transgenic pig with gain-of-function D374Y mutation of human PCSK9, and to contribute to the model of atherosclerosis.[Method] In this study,D374Y-PCSK9 over-expressing plasmids were transferred into Wuzhishan porcine embryonic fibroblasts by electroporation, and somatic cell nuclear transplantation and embryo transfer were used to makeD374Y-PCSK9 over-expressing pig. Using transgenic pig liver, the human PCSK9 expression was assessed by PCR, Southern blot and Western blot in DNA, RNA and protein levels. At the same time, istochemical staining and hematoxylin-eosin (HE) staining were used to identify the pathological changes in liver between D374Y-PCSK9 transgenic pigs and wild-type Wuzhishan pigs.[Result] The positive cloned cells appeared for 3 days, and colony point was formed for 7 days. The PCR results showed that theD374Y-PCSK9 fragments could be spliced into a complete fragment. That means theD374Y-PCSK9 over-expressing plasmids were successfully integrated into fibroblasts of Wuzhishan pig. The screened positive cloned cells were used as donor cells for somatic cell nuclear transfer (SCNT) and transplanted into recipient sows, and finally, the transgenic pig was got. PCR and Southern blot detection results of the DNA samples demonstrated that the entire D374Y-PCSK9 gene was integrated into the genomes. RT-PCR and QPCR were performed using primers specifically recognizing human or pig PCSK9 mRNA. The results showed that the human PCSK9 gene could be normally transcribed in the pig liver and did not influence the transcription of the endogenous pig PCSK9. Surprisingly, the expression of the humanPCSK9 gene could be detected in other organs including the heart, spleen, lung, and kidney, whereas the expression levels of the endogenous pig PCSK9 in these tissues were very low. The western blot results of the proteins were similar to the RNA detection levels. Therefore, the human D374Y-PCSK9 gene integrated into pig genomes was normally transcribed and translated. Besides, transgenic pig's liver had pathological changes were detected by HE staining and histochemical staining and the results showed that the LDLR level in the transgenic pigs' liver was significantly lower than wild-type controls'.[Conclusion] In conclusion, humanPCSK9 protein was successfully over-expressed in Wuzhishan inbred miniature pigs. Compared with wild type pigs, transgenic pigs had a low LDLR level in liver. At the same time, there were obvious pathological changes in transgenic pigs' liver.

Characterization of a Hypertriglyceridemic Transgenic Miniature Pig Model Expressing Human Apolipoprotein CIII

A Novel Swine Model for Evaluation of Dyslipidemia and Atherosclerosis Induced by Human CETP Overexpression.

Hypertriglyceridemia and Delayed Clearance of Fat Load in Transgenic Rabbits Expressing Human Apolipoprotein CIII

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs

Severe Hypertriglyceridemia Appears in Apolipoprotein CⅢ Transgenic Mouse

Production of Transgenic Pigs Over-Expressed PCSK9 D374Y Mutant

CRISPR/Cas9-mediated ApoE-/- and LDLR-/- double gene knockout in pigs elevates serum LDL-C and TC levels

Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.

Preliminary Study on Transgenic Bama Miniature Pig with Liver Overexpression of hNPC1L1

CD8+ T Cells Involved in Metabolic Inflammation in Visceral Adipose Tissue and Liver of Transgenic Pigs

Establishment of a human APOA1 transgenic mouse model

A Novel Mouse Model of Familial Combined Hyperlipidemia and Atherosclerosis.

Multi-Transgenic Minipig Models Exhibiting Potential for Hepatic Insulin Resistance and Pancreatic Apoptosis

Molecular Cloning, Expression and Polymorphism of the Porcine Apolipoprotein A5 Gene in a Jinhua × Pietrain F2 Reference Population

Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs

Pigs transgenic for human thrombomodulin have elevated production of activated protein C

ApoC2 Deficiency Elicits Severe Hypertriglyceridemia and Spontaneous Atherosclerosis: A Rodent Model Rescued from Neonatal Death.

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice*

N -3 polyunsaturated fatty acids attenuates triglyceride and inflammatory factors level in h fat-1 transgenic pigs

Overexpression of Npc1l1 in the Livers of Transgenic Bama Miniature Pigs Accelerates Lipid Peroxidation

Expression of Human Apoaii in Transgenic Rabbits Leads to Dyslipidemia A New Model for Combined Hyperlipidemia